Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluation.
about
Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysisThe real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma.Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database
P2860
Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluation.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Treatments for newly diagnosed ...... cost-effectiveness evaluation.
@ast
Treatments for newly diagnosed ...... cost-effectiveness evaluation.
@en
type
label
Treatments for newly diagnosed ...... cost-effectiveness evaluation.
@ast
Treatments for newly diagnosed ...... cost-effectiveness evaluation.
@en
prefLabel
Treatments for newly diagnosed ...... cost-effectiveness evaluation.
@ast
Treatments for newly diagnosed ...... cost-effectiveness evaluation.
@en
P2093
P1433
P1476
Treatments for newly diagnosed ...... cost-effectiveness evaluation.
@en
P2093
P304
P577
1998-11-01T00:00:00Z